Tag: Guerbet

Irene Bargellini

ET 2019: New microcatheters could help reduce the “everyday challenge” of...

 Irene Bargellini (Pisa, Italy) tells BLearning IR at the first Embolotherapy conference (ET; 26–29 June, Valencia, Spain) that non-target embolization is a frequently under-diagnosed,...

New indication approved for Guerbet’s Lipiodol Ultra Fluid

A new indication for Lipiodol Ultra Fluid (Guerbet) has been approved in Switzerland and in India for chemoembolization (cTACE) of tumours in adults with...

Guerbet receives CE mark approval for SeQure and DraKon microcatheters for...

  SeQure and DraKon (Guerbet), two novel microcatheters for peripheral embolization procedures, are set for commercial launch in Europe. The devices have received the CE...
Essai

Guerbet announces appointment of Leeann Essai as North American head of...

Leeann Essai has joined Guerbet’s executive team as North American head of marketing. In this role, Essai will report to Massimo Carrara, Guerbet vice president...

Guerbet announces commercial partnership with Imalogix

Guerbet has announced a commercial partnership with Imalogix, a company focusing on artificial intelligence process and workflow solutions. The commercial partnership combines Guerbet's diagnostic...

Vectorio®: Efficacy and safety for improved cTACE mixing and delivery

This educational supplement, sponsored by Guerbet, is intended for readers in the EU only. Guerbet obtained the CE mark for its conventional transarterial chemoembolization...

Guerbet launches two new microcatheters for use in embolization procedures

Guerbet has announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumour and vascular aneurysm embolization procedures. The company introduced the...

Guerbet acquires Occlugel and new microsphere technology for initial €3 million...

Guerbet has announced that it has signed an agreement to acquire a laboratory-stage technology developed by Occlugel, a French company specialised in the research...

Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE

Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...

Guerbet acquires IR microcatheter maker Accurate Medical

Guerbet has announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical, which specialises in the development...

Guerbet announces CE mark for Vectorio mixing and injection system for...

Guerbet has announced obtaining the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio. Designed in collaboration with interventional radiologists worldwide,...

German Federal Institute for Drugs and Medical Devices approves new indication...

Guerbet has announced that the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; The German Federal Institute for Drugs and Medical Devices) has now approved Lipiodol...

Thailand FDA approves new indication for Guerbet’s Lipiodol Ultra-Fluide

Guerbet has announced that the Thailand FDA has given approval of a new indication for Lipiodol Ultra-Fluide for selective hepatic intra-arterial injection for visualisation,...

Guerbet expands distribution partnership in Canada with Methapharm

Guerbet has announced that as of 1 February 2017, Methapharm will promote and distribute all Guerbet products in Canada. "As a result of our excellent...